🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Ovarian Hyperstimulation Syndrome Prevention

RecruitingNAAges 19 Years - 42 YearsFemaleAljazeera Hospital
NCT06739759 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Ovarian hyperstimulation is a very hazardous complication of ICSI

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Women with PCOS coming for ICSI Exclusion Criteria: * Women who donnot have PCOS
💊

What it tests

  • Antagonist protocol for IVF
  • Modified Agonist protocol for IVF with additive treatments as HCQ
📍

Where

2 sites
Aljazeerah hospital
Giza, Egypt
Algazeerah
Giza, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy